MedTrace Logo

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

NCT03793400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2019-01-08

No results posted yet for this study

Summary

To evaluate the long-term outcome of active choroidal neovascularization (CNV) in punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) after anti-vascular endothelial factor treatment.

Conditions

  • Choroidal Neovascularization
  • Punctate Inner Choroidopathy

Interventions

DRUG

Bevacizumab Injection

Anti-vascular endothelial growth factor (VEGF)

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2018-04-13
Completion
2018-12-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793400 on ClinicalTrials.gov